多时间点临床与CT影像组学预测高级别浆液性卵巢癌无复发生存
本研究回顾性纳入91例接受新辅助化疗后手术的高级别浆液性卵巢癌患者,提取基线和化疗后CT影像组学特征,用多变量Cox模型评估其对无复发生存(RFS)的预测价值。结果显示,术后纳入手术结局的模型C-statistic为0.69,加入影像组学变化未明显提升(0.7),年龄、术后残留病灶和峰度与较短RFS独立相关。
要点
- 基线临床模型C-statistic为0.53,加入影像组学特征后升至0.63。
- 术后模型纳入基线数据和手术结局,C-statistic为0.69,加入影像组学变化后为0.7。
- 年龄、术后残留病灶和峰度与较短无复发生存独立相关。
核心结论
- CT影像组学特征与临床和遗传数据整合后,可能为预测高级别浆液性卵巢癌的无复发生存提供附加预后价值。
研究设计与样本
- 单中心回顾性研究,纳入91例接受新辅助化疗后手术且基线和化疗后有门静脉期增强CT的高级别浆液性卵巢癌患者。
主要发现
- 仅基线临床数据模型C-statistic为0.53,基线临床加影像组学特征模型为0.63。
- 化疗后模型纳入所有基线数据加基线与化疗后影像组学特征变化,C-statistic为0.63。
- 术后模型纳入所有基线数据加手术结局,C-statistic为0.69。
- 术后数据集加入时间点间影像组学特征变化未明显提升模型性能,C-statistic为0.7。
- 年龄、手术残留病灶和峰度分别与较短无复发生存相关。
临床怎么用
- 可考虑将CT影像组学特征与临床数据整合,用于高级别浆液性卵巢癌患者的无复发生存预测。
- 年龄、术后残留病灶和峰度可作为识别较短无复发生存风险的参考因素。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate the predictive value of clinical, genomic, and radiomics features in estimating recurrence-free survival (RFS) in patients with high-grade serous ovarian carcinoma (HGSOC) treated with neoadjuvant chemotherapy (NACT). METHODS: This single-center, retrospective study included 91 patients with HGSOC who underwent treatment with NACT followed by surgery, and who had portal venous phase contrast enhanced CT imaging at baseline and after NACT. First-order texture features based on 2D segmentation were extracted from baseline and post-NACT CT images for selected disease sites using commercially available texture software. Multivariate Cox models assessed the prognostic significance of features at baseline, after NACT, and post-surgery time points, and model performance in predicting RFS was evaluated using C-statistics. RESULTS: A model including only baseline clinical data had C-statistic 0.53, while a model including both clinical and radiomics features at baseline had C-statistic 0.63. After NACT, a model including all baseline data plus the change in radiomics features between baseline and post-NACT had C-statistic 0.63. Post-surgery, a model including all baseline data plus surgical outcome had C-statistic 0.69. Incorporating changes in radiomic features between time points did not measurably enhance model performance in the post-surgery data set (C-statistic 0.7). Age, residual disease at surgery, and kurtosis were individually associated with shorter RFS. CONCLUSIONS: Radiomic features extracted from CT imaging may offer additive prognostic value for predicting RFS in HGSOC when integrated with clinical and genetic data. Our results support the potential integration of radiomic analysis with clinical data to improve outcome prediction in HGSOC.
引用
- Roller L, Zhou N, Atre I, et al. Toward precision prognosis: Predicting recurrence-free survival in high-grade serous ovarian cancer patients using multi-time point clinical and computed tomography radiomics data. Gynecol Oncol. 2026. PMID: 42391853. doi:10.1016/j.ygyno.2026.06.007
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。